RESUMEN
Objectives: To test our hypothesis that a new modified VAS [mVAS] is superior and more objective than VAS in evaluating pain perception and treatment response between genders who have renal colic pain
Methods: The individuals in patient and control groups were first asked to mark the pain perceived during access of IV line [VAS[IV] score]. Then the patients with renal colic were asked to mark the pain they experienced before treatment [VAS[RC] score] and at 15 and 30 minutes after the administration of the first analgesic drug. The modified VAS scores [mVAS score] were obtained by subtracting the VASIV score from VAS[RC] score
Results: When VAS was used, the female patients had significantly higher level of pain at 0, 15, and 30th minutes than men [p = 0.012, p = 0.001, and p = 0.003, respectively]. However, there was not any significant difference at 0 and 30[th] min between sexes while female patients had significantly higher level of pain scores only at 15[th] minute according to mVAS scores [p = 0.027]
Conclusion: We think that the mVAS is superior and more objective than VAS in evaluating pain perception and abolished the difference in the perceived level of pain due to gender
Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Adulto , Cólico Renal , Dolor , Analgesia , Estudios ProspectivosRESUMEN
To investigate diagnostic value of ischemia-modified albumin [IMA] levels in patients applying to emergency with symptoms of acute coronary syndrome [ACS] and acute ischemic stroke [AIS]. Two patient groups [ACS and AIS] and a control group were constituted. The study was discontinued upon reaching 30 patients in each group. Following patient approval at the initial visit, a total of 10 ml venous blood sample was obtained from all patients with a high clinical suspicion of ACS and AIS. The Troponin I and the IMA levels were determined in the blood samples. Statistically significant higher IMA values were determined in the patient groups compared to the control group [p < 0.001 for both groups]. No statistically significant correlation was found between the IMA and the Troponin I values in the ACS and the AIS groups [p>0.05 for both groups]. The sensitivity of IMA was 83% and 87% for ACS and AIS, respectively. The specificity of IMA was 90% and 87% for ACS and AIS, respectively. The sensitivity and specificity values, determined according to the optimal cut-off values in the groups demonstrated that IMA could be a useful diagnostic marker in ACS and AIS patients